3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Cervical Neoplasms
14
Breast Neoplasms
10
Ovarian Neoplasms
7
Endometrial Neoplasms
7
Vulvar Neoplasms
6
Colonic Neoplasms
5
Rectal Neoplasms
4
Pancreatic Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Vaginal Neoplasms
3
Urinary Bladder Neoplasms
3
Prostatic Neoplasms
3
Obesity
3
Fallopian Tube Neoplasms
3
Triple Negative Breast Neoplasms
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Leukemia
2
Kidney Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Weight Loss
1
Uterine Neoplasms
1
Uterine Cervical Dysplasia
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Interventions
Paclitaxel
13
pembrolizumab
8
Carboplatin
7
Surveys and Questionnaires
6
Cisplatin
6
Brachytherapy
5
Doxorubicin
4
Docetaxel
4
Pemetrexed
3
Hyperthermic Intraperitoneal Chemotherapy
3
Gemcitabine
3
FANG vaccine
3
Biopsy
3
osimertinib
2
olaparib
2
niraparib
2
durvalumab
2
adavosertib
2
Trastuzumab
2
Topotecan
2
Taxes
2
Standard of Care
2
Sentinel Lymph Node Biopsy
2
Saline Solution
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiation
2
Oxaliplatin
2
Nivolumab
2
Music Therapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Methods
×
Gynecologic
×
Clear all
NCT05939440
2025-06-05
P-COC
University of Alabama at Birmingham
Phase NA
Completed
60 enrolled